Guest editors: Joseph Buxbaum and Catalina Betancur
Genome Medicine is pleased to announce a special issue on Disease Neurogenomics for publication in Fall 2017, guest edited by Prof. Joseph Buxbaum, Icahn School of Medicine at Mount Sinai and Dr. Catalina Betancur, INSERM. The issue will explore the genetic and genomic landscape of brain disorders, with a special focus on neurodevelopmental, neuropsychiatric and neurodegenerative diseases. The issue aims to capture the advances made in understanding the impact of genetic and genomic variation on neuronal function, networks and the transition to dysregulation and disease.
We are now inviting the submission of Research, Method and Software manuscripts of broad interest describing advances in the genomics of brain disorders in the context of translational and clinical research on the following topics:
- Genetic architecture and disease risk
- Whole genome, exome and RNA sequencing and other ‘omic technologies
- Single cell analyses
- Genetic epidemiology
- Neuronal dysfunction and disease mechanisms
- Disease models (including iPSCs and organoids)
- Risk prediction
- Systems neuroscience and brain connectomics
- Imaging genetics
- Translational and precision genomics (including targeted therapies)
- Genome editing
Submission deadline: 15 August 2017
To submit your manuscript, please use Genome Medicine’s online submission system and indicate in your covering letter that you would like the article to be considered for the ‘Disease Neurogenomics’ special issue. If you would like to enquire about the suitability of a manuscript for consideration, please email email@example.com.